Related references
Note: Only part of the references are listed.Unique neuromyelitis optica pathology produced in na⟨ve rats by intracerebral administration of NMO-IgG
Nithi Asavapanumas et al.
ACTA NEUROPATHOLOGICA (2014)
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica
Raffaella Greco et al.
ANNALS OF NEUROLOGY (2014)
Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis
Maarten J. Titulaer et al.
ANNALS OF NEUROLOGY (2014)
The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica
Claudia F. Lucchinetti et al.
BRAIN PATHOLOGY (2014)
Neuromyelitis optica: clinical features, immunopathogenesis and treatment
S. Jarius et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica
Julien Ratelade et al.
EXPERIMENTAL NEUROLOGY (2014)
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
Manabu Araki et al.
Modern Rheumatology (2014)
Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients
Liene Elsone et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Teaching NeuroImages: MRI in advanced neuromyelitis optica
Sherri A. Braksick et al.
NEUROLOGY (2014)
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Douglas Kazutoshi Sato et al.
NEUROLOGY (2014)
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study
Manabu Araki et al.
NEUROLOGY (2014)
Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study
Nasrin Asgari et al.
BMC NEUROLOGY (2013)
Efficacy of Intravenous Cyclophosphamide Therapy for Neuromyelitis Optica Spectrum Disorder
Hiroaki Yaguchi et al.
INTERNAL MEDICINE (2013)
Distinguishing Optic Neuritis in Neuromyelitis Optica Spectrum Disease From Multiple Sclerosis: A Novel Magnetic Resonance Imaging Scoring System
Mithu Storoni et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2013)
The history of neuromyelitis optica
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Steroid-responsive hearing impairment in NMO-IgG/aquaporin-4-antibody-positive neuromyelitis optica
S. Jarius et al.
JOURNAL OF NEUROLOGY (2013)
Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica
Takashi Kageyama et al.
JOURNAL OF NEUROLOGY (2013)
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
Joanna Kitley et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
Sean J. Pittock et al.
LANCET NEUROLOGY (2013)
Neuropathic pruritus (itch) in neuromyelitis optica
Liene Elsone et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica
Takahiro Makino et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum
M. Ringelstein et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient
Nasrin Asgari et al.
NEUROLOGY (2013)
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica
Yujuan Jiao et al.
NEUROLOGY (2013)
Plasmablasts as Migratory IgG-Producing Cells in the Pathogenesis of Neuromyelitis Optica
Norio Chihara et al.
PLOS ONE (2013)
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica Implication for Cellular Immune Responses
Bernd C. Kieseier et al.
JAMA NEUROLOGY (2013)
Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy
Ilya Ayzenberg et al.
JAMA NEUROLOGY (2013)
A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder
Su-Hyun Kim et al.
JAMA NEUROLOGY (2013)
Anti-Aquaporin-4 Monoclonal Antibody Blocker Therapy for Neuromyelitis Optica
Lukmanee Tradtrantip et al.
ANNALS OF NEUROLOGY (2012)
Neutrophil Protease Inhibition Reduces Neuromyelitis Optica-Immunoglobulin G-Induced Damage in Mouse Brain
Samira Saadoun et al.
ANNALS OF NEUROLOGY (2012)
Lack of Response to Pulse Cyclophosphamide in Neuromyelitis Optica: Evaluation of 7 Patients
Denis B. Bichuetti et al.
ARCHIVES OF NEUROLOGY (2012)
Hypothermia, Hypotension, Hypersomnia, and Obesity Associated With Hypothalamic Lesions in a Patient Positive for the Anti-aquaporin 4 Antibody
Keisuke Suzuki et al.
ARCHIVES OF NEUROLOGY (2012)
Epidemiology of Neuromyelitis Optica in the United States A Multicenter Analysis
Maureen A. Mealy et al.
ARCHIVES OF NEUROLOGY (2012)
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
Joanna Kitley et al.
BRAIN (2012)
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Aquaporin 4 and neuromyelitis optica
Marios C. Papadopoulos et al.
LANCET NEUROLOGY (2012)
The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease
Dean M. Wingerchuk et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
Ju-Hong Min et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?
Su-Hyun Kim et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
TWO CASES OF LUMBOSACRAL MYELORADICULITIS WITH ANTI-AQUAPORIN-4 ANTIBODY
Yoshiki Takai et al.
NEUROLOGY (2012)
Influence of pregnancy on neuromyelitis optica spectrum disorder
W. Kim et al.
NEUROLOGY (2012)
Serologic diagnosis of NMO A multicenter comparison of aquaporin-4-IgG assays
P. J. Waters et al.
NEUROLOGY (2012)
DOES NATALIZUMAB THERAPY WORSEN NEUROMYELITIS OPTICA?
Anu Jacob et al.
NEUROLOGY (2012)
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Joanna Kitley et al.
NEUROLOGY (2012)
Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
Jonathan James Downer et al.
NEURORADIOLOGY (2012)
White Matter Atrophy and Cognitive Dysfunctions in Neuromyelitis Optica
Frederic Blanc et al.
PLOS ONE (2012)
Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes
Shannon R. Hinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
Maya H. Buch et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
A Benign Form of Neuromyelitis Optica Does It Exist?
Nicolas Collongues et al.
ARCHIVES OF NEUROLOGY (2011)
Failure of Autologous Hematopoietic Stem Cell Transplantation to Prevent Relapse of Neuromyelitis Optica
Marcelo Matiello et al.
ARCHIVES OF NEUROLOGY (2011)
Neuromyelitis optica-IgG(+) optic neuritis associated with celiac disease and dysgammaglobulinemia: A role for tacrolimus?
Isabelle Meyts et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2011)
Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels
Ichiro Nakashima et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Ocular Oscillations in the Neuromyelitis Optica Spectrum
Rabih Hage et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2011)
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
S. Jarius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
SYNDROME OF INAPPROPRIATE ANTIDIURESIS MAY HERALD OR ACCOMPANY NEUROMYELITIS OPTICA
R. Iorio et al.
NEUROLOGY (2011)
Pain in neuromyelitis optica and its effect on quality of life A cross-sectional study
Y. Kanamori et al.
NEUROLOGY (2011)
Azathioprine Tolerability, efficacy, and predictors of benefit in neuromyelitis optica
C. Costanzi et al.
NEUROLOGY (2011)
CSF COMPLEMENTS SERUM FOR EVALUATING PARANEOPLASTIC ANTIBODIES AND NMO-IgG
Andrew McKeon et al.
NEUROLOGY (2011)
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
Norio Chihara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Intractable Vomiting as the Initial Presentation of Neuromyelitis Optica
Metha Apiwattanakul et al.
ANNALS OF NEUROLOGY (2010)
Neuromyelitis optica preceded by hyperCKemia episode
N. Suzuki et al.
NEUROLOGY (2010)
Supraspinal demyelinating lesions in neuromyelitis optica display a typical astrocyte pathology
D-H. Lee et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2010)
Cloud-like Enhancement Is a Magnetic Resonance Imaging Abnormality Specific to Neuromyelitis Optica
Shoichi Ito et al.
ANNALS OF NEUROLOGY (2009)
Prediction of Neuromyelitis Optica Attack Severity by Quantitation of Complement-Mediated Injury to Aquaporin-4-Expressing Cells
Shannon R. Hinson et al.
ARCHIVES OF NEUROLOGY (2009)
Treatment of Neuromyelitis Optica With Mycophenolate Mofetil
Anu Jacob et al.
ARCHIVES OF NEUROLOGY (2009)
Narcolepsy as an initial manifestation of neuromyelitis optica with antiaquaporin-4 antibody
Toru Baba et al.
JOURNAL OF NEUROLOGY (2009)
Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica
S. Viegas et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Neuromyelitis optica: Effect of gender
Dean M. Wingerchuk
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab
H. L. Pellkofer et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders
S. M. Magana et al.
NEUROLOGY (2009)
Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G
B. Mark Keegan et al.
ANNALS OF NEUROLOGY (2008)
Treatment of Neuromyelitis Optica With Rituximab Retrospective Analysis of 25 Patients
Anu Jacob et al.
ARCHIVES OF NEUROLOGY (2008)
Acute disseminating encephalomyelitis in neuromyelitis optica
Roni Eichel et al.
ARCHIVES OF NEUROLOGY (2008)
Neuromyelitis Optica and non-organ-specific Autoimmunity
Sean J. Pittock et al.
ARCHIVES OF NEUROLOGY (2008)
Aquaporin-4 autoantibodies in a paraneoplastic context
Sean J. Pittock et al.
ARCHIVES OF NEUROLOGY (2008)
A rush to judgment on Th17
Lawrence Steinman
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2
Shannon R. Hinson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Preferential spinal central gray matter involvement in neuromyelitis optica - An MRI study
M. Nakamura et al.
JOURNAL OF NEUROLOGY (2008)
NMO-IgG predicts the outcome of recurrent optic neuritis
M. Matiello et al.
NEUROLOGY (2008)
Pregnancy outcome of women exposed to azathioprine during pregnancy
Lee Hilary Goldstein et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2007)
Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis
S. Watanabe et al.
MULTIPLE SCLEROSIS (2007)
Anti-aquaporin 4 antibody in Japanese multiple sclerosis: the presence of optic-spinal multiple sclerosis without long spinal cord lesions and anti-aquaporin 4 antibody
Masami Tanaka et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
A secondary progressive clinical course is uncommon in neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2007)
Study of mitoxantrone for the treatment of recurrent neuromyelitis Optica (Devic disease)
Bianca Weinstock-Guttman et al.
ARCHIVES OF NEUROLOGY (2006)
Revised diagnostic criteria for neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2006)
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis
BG Weinshenker et al.
ANNALS OF NEUROLOGY (2006)
Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica
T Misu et al.
NEUROLOGY (2005)
An open label study of the effects of rituximab in neuromyelitis optica
BAC Cree et al.
NEUROLOGY (2005)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG
SA Cross et al.
ANNALS OF NEUROLOGY (2003)
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
CF Lucchinetti et al.
BRAIN (2002)